Search Results

Drugs in the medical treatment of Cushing's syndrome

Author: Schteingart, David E

Source: Expert Opinion on Emerging Drugs, Volume 14, Number 4, December 2009 , pp. 661-671(11)

Publisher: Informa Healthcare

Adverse Endocrine and Metabolic Effects of Psychotropic Drugs: Selective Clinical Review

Authors: Bhuvaneswar, Chaya G.; Baldessarini, Ross J.; Harsh, Veronica L.; Alpert, Jonathan E.

Source: CNS Drugs, Volume 23, Number 12, 1 December 2009 , pp. 1003-1021(19)

Publisher: Adis International

Established therapies and novel targets in the treatment of Parkinson's disease

Authors: Dézsi, Livia; Vécsei, László

Source: Expert Review of Clinical Pharmacology, Volume 2, Number 6, November 2009 , pp. 631-644(14)

Publisher: Expert Reviews

Translating 5-HT₄ receptor pharmacology

Author: sanger, g. j.

Source: Neurogastroenterology and Motility, Volume 21, Number 12, December 2009 , pp. 1235-1238(4)

Publisher: Blackwell Publishing

Current and Future Therapeutic Strategies for Parkinson's Disease

Authors: Outeiro, Tiago F.; Ferreira, Joaquim

Source: Current Pharmaceutical Design, Volume 15, Number 34, December 2009 , pp. 3968-3976(9)

Publisher: Bentham Science Publishers

Medical Therapy of Acromegaly: Efficacy and Safety of Somatostatin Analogues

Authors: Feelders, Richard A.; Hofland, Leo J.; van Aken, Maarten O.; Neggers, Sebastian J.; Lamberts, Steven W.J.; de Herder, Wouter W.; >Aart-Jan van der Lely,

Source: Drugs, Volume 69, Number 16, 12 November 2009 , pp. 2207-2226(20)

Publisher: Adis International

Recent Progress in the Development of mGluR4 Positive Allosteric Modulators for the Treatment of Parkinson's Disease

Authors: Lindsley, Craig W.; Niswender, Colleen M.; Engers, Darren W.; Hopkins, Corey R.

Source: Current Topics in Medicinal Chemistry, Volume 9, Number 10, July 2009 , pp. 949-963(15)

Publisher: Bentham Science Publishers

Adenosine A2A Receptors in Psychopharmacology: Modulators of Behavior, Mood and Cognition

Authors: Shen, Hai-Ying; Chen, Jiang-Fan

Source: Current Neuropharmacology, Volume 7, Number 3, September 2009 , pp. 195-206(12)

Publisher: Bentham Science Publishers

Critical review of ropinirole and pramipexole - putative dopamine D₃-receptor selective agonists - for the treatment of RLS

Authors: Varga, L. I.; Ako-Agugua, N.; Colasante, J.; Hertweck, L.; Houser, T.; Smith, J.; Watty, A. A.; Nagar, S.; Raffa, R. B.

Source: Journal of Clinical Pharmacy & Therapeutics, Volume 34, Number 5, October 2009 , pp. 493-505(13)

Publisher: Blackwell Publishing

Prevention of OHSS - dopamine agonists

Authors: Busso, Cristiano E.; Garcia-Velasco, Juan; Gomez, Raúl; Álvarez, Claudio; Simón, Carlos; Pellicer, Antonio

Source: Reproductive BioMedicine Online, Volume 19, Number 1, July 2009 , pp. 43-51(9)

Publisher: Reproductive Healthcare Ltd

Dopamine receptor agonists: Worsening of restless legs syndrome, with nocturnal eating and weight gain in an elderly patient: case report

Source: Reactions, Volume 1, Number 1260, 2009-07-11 , pp. 14-14(1)

Publisher: Adis International

Dopamine receptor agonists: Pisa syndrome: 8 case reports

Source: Reactions, Volume 1, Number 1256, 2009-06-13 , pp. 15-16(2)

Publisher: Adis International

The Glycine Reuptake Inhibitor Org 25935 Interacts With Basal and Ethanol-Induced Dopamine Release in Rat Nucleus Accumbens

Authors: Lidö, Helga Höifödt; Stomberg, Rosita; Fagerberg, Anne; Ericson, Mia; Söderpalm, Bo

Source: Alcoholism Clinical and Experimental Research, Volume 33, Number 7, July 2009 , pp. 1151-1157(7)

Publisher: Blackwell Publishing

Dopamine receptor agonists: Compulsive gambling and hypersexuality: 7 case reports

Source: Reactions, Volume 1, Number 1254, 2009-05-30 , pp. 20-21(2)

Publisher: Adis International

Histamine H3-Receptor Inverse Agonists as Novel Antipsychotics

Author: Ito, Chihiro

Source: Central Nervous System Agents in Medicinal Chemistry(Formerly Current Medicinal, Volume 9, Number 2, June 2009 , pp. 132-136(5)

Publisher: Bentham Science Publishers

Pathological laughing and crying may be caused by many neurological disorders and is highly responsive to treatment

Author: Adis International Limited,

Source: Drugs & Therapy Perspectives, Volume 25, Number 4, April 2009 , pp. 18-20(3)

Publisher: Adis International

Improve symptoms of restless legs syndrome with dopaminergic agents and other treatment options

Author: Adis International Limited,

Source: Drugs & Therapy Perspectives, Volume 25, Number 5, May 2009 , pp. 9-12(4)

Publisher: Adis International

Dopamine agonist administration causes a reduction in endometrial implants through modulation of angiogenesis in experimentally induced endometriosis

Authors: Novella-Maestre, Edurne; Carda, Carmen; Noguera, Inmaculada; Ruiz-Saur, Amparo; Garca-Velasco, Juan Antonio; Simn, Carlos; Pellicer, Antonio

Source: Human Reproduction, Volume 24, Number 5, 13 May 2009 , pp. 1025-1035(11)

Publisher: Oxford University Press

Cannabinoid CB1 receptor antagonists as potential pharmacotherapies for drug abuse disorders

Authors: Beardsley, Patrick; Thomas, Brian; Mcmahon, Lance

Source: International Review of Psychiatry, Volume 21, Number 2, April 2009 , pp. 134-142(9)

Publisher: Informa Healthcare

Recovery of Locomotor Function with Combinatory Drug Treatments Designed to Synergistically Activate Specific Neuronal Networks

Author: Guertin, Pierre A.

Source: Current Medicinal Chemistry, Volume 16, Number 11, April 2009 , pp. 1366-1371(6)

Publisher: Bentham Science Publishers